Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 8Prostatic Neoplasms 7Leukemia, Myeloid, Acute 6Colorectal Neoplasms 5Breast Neoplasms 5Stomach Neoplasms 4Leukemia, Myelomonocytic, Acute 4Leukemia, Monocytic, Acute 4Leukemia, Megakaryoblastic, Acute 4Leukemia, Erythroblastic, Acute 4Congenital Abnormalities 4Pancreatic Neoplasms 3Multiple Myeloma 3Lymphoma, Mantle-Cell 3Lung Neoplasms 3Colonic Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Carcinoma, Hepatocellular 3Venous Thromboembolism 2Recurrence 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Papillomavirus Infections 2Neuroblastoma 2Neoplasm Metastasis 2Motor Activity 2Melanoma 2Lymphoma, Follicular 2Lymphoma 2Leukemia, Eosinophilic, Acute 2Leukemia, Basophilic, Acute 2

Interventions

Temozolomide 13Filgrastim 8Carboplatin 8Radiotherapy 7Magnetic Resonance Spectroscopy 7Etoposide 7Cisplatin 7Cyclophosphamide 6Bevacizumab 6Vincristine 4Thiotepa 4Carmustine 4sargramostim 3Surveys and Questionnaires 3Peripheral Blood Stem Cell Transplantation 3Methotrexate 3Lapatinib 3Irinotecan 3Azacitidine 3veliparib 2alovudine 2aldesleukin 2Tamoxifen 2Radiotherapy, Conformal 2Radiation 2Paclitaxel 2Mental Status and Dementia Tests 2Imatinib Mesylate 2Granulocyte-Macrophage Colony-Stimulating Factor 2Granulocyte Colony-Stimulating Factor 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Ependymoma × Observation × Clear all
NCT01096368 2026-04-30

Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Ependymoma

Children's Oncology Group

Phase 3 Completed
479 enrolled 24 charts

Ependymoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡